NCT05874180 - A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers in Fed Condition | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 9, 2023

Primary Completion Date

February 1, 2023

Study Completion Date

February 3, 2023

Conditions

Healthy Subjects

Interventions

DRUG

DW6013

"Drug: DW6013 Single oral administration of DW6013 in fed condition~Drug: Linagliptin and Metformin Single oral administration of Linagliptin and Metformin in fed condition"

Trial Locations (1)

Unknown

Chungbuk National University Hospital, Cheongju-si